Grapefruit Usa Inc Revenue Growth Rates (GPFT), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Grapefruit Usa Inc   (GPFT)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

GPFT's Revenue Growth by Quarter and Year

Grapefruit Usa Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GPFT Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
4th Quarter December -
3rd Quarter September 0.00
2nd Quarter June 0.02
1st Quarter March 0.01
FY 0.03

GPFTs Annual Revenue
Grapefruit Usa Inc 's Revenue in the fiscal year 2021 $ 0.59 millions
Grapefruit Usa Inc 's Revenue in the fiscal year 2020 $ 3.67 millions
Grapefruit Usa Inc 's Revenue in the fiscal year 2019 $ 0.45 millions
Grapefruit Usa Inc 's Revenue in the fiscal year 2018 $ 0.00 millions
Grapefruit Usa Inc 's Revenue in the fiscal year 2017 $ 0.04 millions




GPFT Revenue third quarter 2022 Y/Y Growth Comment
Grapefruit Usa Inc reported drop in Revenue in the third quarter 2022 by -98.03% to $ 0.00 millions, from the same quarter in 2021.
The fall in the third quarter 2022 Grapefruit Usa Inc 's Revenue compares unfavorably to the Company's average Revenue increase of 16.26%.

Looking into third quarter 2022 results within Medical Laboratories industry 30 other companies have achieved higher Revenue growth. While Grapefruit Usa Inc ' s Revenue meltdown of -98.03% ranks overall at the positon no. 3529 in the third quarter 2022.


GPFT Revenue ( Y/Y Growth %) 2022
 2021 2020 2019
4th Quarter December - - 808.33 % 140 %
3rd Quarter September -98.03 % -88.55 % - -
2nd Quarter June -75 % -90.91 % - -
1st Quarter March -97.14 % -10.26 % 18.18 % -
FY   - -84.2 % 715.56 % -

Financial Statements
Grapefruit Usa Inc 's third quarter 2022 Revenue $ 0.00 millions GPFT's Income Statement
Grapefruit Usa Inc 's third quarter 2021 Revenue $ 0.15 millions Quarterly GPFT's Income Statement


GPFT Revenue (Quarter on Quarter Growth %)

 2022
 2021 2020 2019
4th Quarter December - - -16.79 % -
3rd Quarter September -85.19 % 87.5 % 48.86 % -
2nd Quarter June 100 % -77.14 % 125.64 % -
1st Quarter March - -67.89 % 225 % 560 %
FY (Year on Year)   - -84.2 % 715.56 % -


Back to GPFT Growth rate Comparisons >> Back to GPFT Growth rate Comparisons >>


Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #31
Healthcare Sector #509
Overall #3529

Revenue Y/Y Growth Statistics
High Average Low
1026.02 % 16.26 % -120.31 %
(Jun 30 2016)   (Sep. 30, 2014)
Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #31
Healthcare Sector #509
Overall #3529
Revenue Y/Y Growth Statistics
High Average Low
1026.02 % 16.26 % -120.31 %
(Jun 30 2016)   (Sep. 30, 2014)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Grapefruit Usa Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


GPFT's III. Quarter Q/Q Revenue Comment
Recent accomplishment of 0.00 millions by Grapefruit Usa Inc come out even worse considering the 0.02 millions a quarter before.

Within Medical Laboratories industry Grapefruit Usa Inc achieved highest sequential Revenue growth. While Grapefruit Usa Inc 's Revenue growth quarter on quarter, overall rank is .


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


GPFT's III. Quarter Q/Q Revenue Comment
Recent accomplishment of 0.00 millions by Grapefruit Usa Inc come out even worse considering the 0.02 millions a quarter before.

Within Medical Laboratories industry Grapefruit Usa Inc achieved highest sequential Revenue growth. While Grapefruit Usa Inc 's Revenue growth quarter on quarter, overall rank is .


Grapefruit Usa Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2022)		 12 Months Ending
(Jun 30 2022)		 12 Months Ending
(Mar 31 2022)		 12 Months Ending
(Dec 31 2021)		 12 Months Ending
(Sep 30 2021)
Cumulative Revenue 12 Months Ending $ 0.03 $ 0.19 $ 0.24 $ 0.59 $ 1.68
Y / Y Revenue Growth (TTM) -97.92 % -93.45 % -93.28 % -83.96 % -37.82 %
Year on Year Revenue Growth Overall Ranking # 3529 # 3377 # 3285 # 3711 # 3525
Seqeuential Revenue Change (TTM) -81.2 % -23.97 % -58.61 % -64.92 % -40.71 %
Seq. Revenue Growth (TTM) Overall Ranking # 3507 # 3679 # 3545 # 3894 # 1318


Cumulative Revenue growth Comment
Grapefruit Usa Inc 's cumulative 12 months Revenue continue to drop, but on the faster rate at -97.92% year on year, at Sep 30 2022 compare to the -93.45% decrease at Jun 30 2022. If the Grapefruit Usa Inc 's fiscal year would end at Sep 30 2022, annual Revenue would be $0 millions.

In the Healthcare sector 508 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3377 to 3529.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 30
Healthcare Sector # 509
Overall # 3529

Revenue TTM Y/Y Growth Statistics
High Average Low
1026.02 %
 16.26 %
-120.31 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 30
Sector # 507
S&P 500 # 3507
Cumulative Revenue growth Comment
Grapefruit Usa Inc 's cumulative 12 months Revenue continue to drop, but on the faster rate at -97.92% year on year, at Sep 30 2022 compare to the -93.45% decrease at Jun 30 2022. If the Grapefruit Usa Inc 's fiscal year would end at Sep 30 2022, annual Revenue would be $0 millions.

In the Healthcare sector 508 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3377 to 3529.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 30
Healthcare Sector # 509
Overall # 3529

Revenue TTM Y/Y Growth Statistics
High Average Low
1026.02 %
16.26 %
-120.31 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 30
Sector # 507
S&P 500 # 3507




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
GPFT's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2022
Nrc Health-0.20%$ -0.201 millions
Livanova Plc-0.24%$ -0.241 millions
Healthcare Services Group Inc -0.27%$ -0.265 millions
Catalent Inc -0.29%$ -0.293 millions
Asensus Surgical Inc -0.31%$ -0.311 millions
Liquidia Corporation-0.43%$ -0.429 millions
Integra Lifesciences Holdings Corp-0.43%$ -0.432 millions
Pediatrix Medical Group Inc -0.62%$ -0.615 millions
China Pharma Holdings Inc-0.64%$ -0.642 millions
Acadia Pharmaceuticals Inc -0.68%$ -0.682 millions
Bausch and Lomb Corp-0.74%$ -0.738 millions
Amgen Inc -0.81%$ -0.805 millions
Syneos Health Inc -0.89%$ -0.891 millions
Hologic Inc-0.93%$ -0.925 millions
Innovage Holding Corp -1.07%$ -1.070 millions
Regen Biopharma Inc -1.09%$ -1.088 millions
Procyon Corporation-1.20%$ -1.200 millions
Precipio inc -1.38%$ -1.380 millions
Ati Physical Therapy Inc -1.40%$ -1.397 millions
Ocular Therapeutix Inc -1.55%$ -1.547 millions
Alpine Immune Sciences Inc -1.75%$ -1.750 millions
Surgalign Holdings Inc -1.79%$ -1.786 millions
Tenet Healthcare Corp-1.90%$ -1.900 millions
Teleflex Incorporated-1.92%$ -1.923 millions
Novocure Limited-1.95%$ -1.952 millions
Fresenius Medical Care Ag-1.99%$ -1.990 millions
Hca Healthcare Inc -2.00%$ -1.997 millions
Dynatronics Corporation-2.01%$ -2.014 millions
Royalty Pharma Plc-2.10%$ -2.101 millions
National Healthcare Corp-2.13%$ -2.130 millions


About Grapefruit Usa Inc Revenue Growth Rates (GPFT), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Grapefruit Usa Inc (CIK 1205181).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001493152-22-032974
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Grapefruit Usa Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.